To hear about similar clinical trials, please enter your email below
Trial Title:
Development of a Culturally Tailored Resilience-building Intervention for Chinese American's Advance Care Planning Discussions
NCT ID:
NCT06247215
Condition:
Advance Care Planning
Neoplasms
Heart Diseases
Conditions: Official terms:
Heart Diseases
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Supportive Care
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
Culturally tailored resilience-building intervention
Description:
A booklist teaching resilience skills for advance care planning discussions
Arm group label:
Experimental
Summary:
Less than 15% of Chinese Americans complete advance directives. That is less than half of
the 37% completion rate in the US general population. This disparity in the use of
advance care planning between White Americans and Chinese Americans may extend to
disparities in end-of-life care. To address such disparities in end-of-life care, we will
develop and assess the acceptability of a culturally tailored resilience-building
intervention to help Chinese Americans with cancer or heart disease and their family
caregivers engage in advance care planning discussions.
Detailed description:
The overall objective of this cross-sectional pilot study is to develop a culturally
tailored resilience-building intervention for Chinese Americans with cancer or heart
disease in Chicago. A qualitative analysis of semi-structured interviews will be
conducted to identify how religious leaders addressed death-related topics with Chinese
Americans with cancer or heart disease in Chicago. In addition, a usability test of a
resilience-building intervention prototype will be conducted to to understand the
feasibility and acceptability among 18 pairs of Chinese Americans and their family
caregivers (9 pairs with cancer and 9 pairs with heart disease).
Criteria for eligibility:
Criteria:
Inclusion criteria for patient participants:
- Age ≥ 18 years of age
- Having a cancer diagnosis or a heart failure diagnosis documented in the electronic
medical record
- Being able to read and respond to questions in English or Mandarin
- Having a family caregiver who is responsible for the care and willing to participate
in the study
- Being of non-Hispanic Asian race/ethnicity
Exclusion criteria for patient participants:
- Having cognitive impairment per a Short Portable Mental Status Questionnaire with
more than 3 errors
- Having received heart transplantation or a left ventricular assist device • Having
completed an advance directive
- Being born in the US
Inclusion criteria for identified family caregivers:
- Age ≥ 18 years
- Being able to read and respond to questions in English or Mandarin
- Being identified by the patient as a family caregiver
Gender:
All
Minimum age:
18 Years
Maximum age:
80 Years
Healthy volunteers:
No
Start date:
September 15, 2024
Completion date:
March 31, 2025
Lead sponsor:
Agency:
University of Illinois at Chicago
Agency class:
Other
Collaborator:
Agency:
University of Chicago
Agency class:
Other
Collaborator:
Agency:
Rush University Medical Center
Agency class:
Other
Source:
University of Illinois at Chicago
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06247215
